Association between 22 cytokine gene polymorphisms and dilated cardiomyopathy in Macedonian patients

Kardiologia Polska

Volumn 67, Issue 11, 2009, Pages 1237-1247

  Spiroska, Vera ^a   Kedev, Sashko ^a   Antov, Slobodan ^a   Trajkov, Dejan ^a   Petlichkovski, Aleksandar ^a   Hristomanova, Slavica ^a   Djulejic, Eli ^a   Paneva, Meri ^a   Senev, Aleksandar ^a   Spiroski, Mirko ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Cytokine polymorphism; Dilated cardiomyopathy; Republic of Macedonia

Indexed keywords

CYTOKINE;

ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MACEDONIA (REPUBLIC); SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 74849138984     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Olson TM, Thibodeau SN, Lundquist PA, et al. Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy. J Med Genet 1995; 32: 876-80.
2. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867-76.
3. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005; 112: 3577-83.
4. Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, MD. MIM Number:*607093:6/15/2007. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
5. Pankuweit S, Ruppert V, Maisch B. Inflammation in dilated cardiomyopathy. Herz 2004; 29: 788-93.
6. Kubota T, McNamara DM, Wang JJ, et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST investigators for TNF genotype analysis. Vesnarinone survival trial. Circulation 1998; 97: 2499-501.
7. Tiret L, Mallet C, Poirier O, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000; 35: 29-35.
8. Alikasifoglu M, Tokgözoglu L, Acil T, et al. Tumor necrosis factor - alpha polymorphism in Turkish patients with dilated cardiomyopathy. Eur J Heart Fail 2003; 5: 161-3.
9. Ito M, Takahashi H, Fuse K, et al. Polymorphisms of tumor necrosis factor-alpha and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy. Jpn Heart J 2000; 41: 183-91.
10. Trajkov D, Arsov T, Petlichkovski A, et al. Cytokine gene polymorphisms in population of ethnic Macedonians. Croat Med J 2005; 46: 685-92.
11. Trajkov D, Atanasovska-Stojanovska A, Petlichkovski A, et al. IL-1 Gene Cluster Polymorphisms in the Macedonian Population. Maced J Med Sci 2008; 1: 26-33.
12. Trajkov D, Arsov T, Petlichkovski A, et al. Distribution of the 22 cytokine gene polymorphisms in healthy Macedonian population. Bratisl Lek Listy 2009; 110: 7-17.
13. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-2.
14. Towner P. Purification of DNA. In: Brown TA (ed.). Essential molecular biology. Oxford University Press, Oxford 1995; 47-54.
15. Spiroski M, Arsov T, Petlichkovski A, et al. Case Study: Macedonian Human DNA Bank (hDNAMKD) as a source for public health Genetics. In: Georgieva L, Burazeri G (eds.). Health determinants in the scope of new public health. Hans Jacobs Company, Sofia 2005; 33-44.
16. Tseng LH, Chen PJ, Lin MT, et al. Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphism. J Immunol Methods 2002; 267: 151-6.
17. Lancaster A, Nelson MP, Meyer D, et al. PyPop: a software framework for population genomics: analyzing large-scale multilocus genotype data. Pac Symp Biocomput 2003; 514-25.
18. Lancaster AK, Single RM, Solberg OD, et al. PyPop update-a software pipeline for large-scale multilocus population genomics. Tissue Antigens 2007; 69: 192-7.
19. Single RM, Meyer D, Mack SJ, et al. 14th International HLA and Immunogenetics Workshop: report of progress in methodology, data collection, and analyses. Tissue Antigens 2007; 69: 185-7.
20. Guo S, Thomson E. Performing the exact test of Hardy Weinberg proportion for multiple alleles. Biometrics 1992; 48: 361.
21. Schneider S, Roessli D, Excoffier L. Arlequin version 2.000: a software for population genetics data analysis. Geneva (Switzerland): Genetics and Biometry Laboratory, University of Geneva; 2000.
22. Rice TK, Schork NJ, Rao DC. Methods for handling multiple testing. Adv Genet 2008; 60: 293-308.
23. Holm S. A simple sequentially rejective Bonferroni test procedure. Scand J Statist 1979; 6: 65-70.
24. Bijlsma FJ, vanKuik J, Tilanus MG, et al. Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. J Heart Lung Transplant 2002; 21: 340-6.
25. Liu W, Li WM, Gao C, et al. The research on associating the single nucleotide polymorphism of CTLA-4 gene promoter region with idiopathic dilated cardiomyopathy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006; 23: 198-201.
26. Webber SA, Boyle GJ, Gribar S, et al. Polymorphisms in cytokine genes do not predict progression to end-stage heart failure in children. Cardiol Young 2002; 12: 461-4.
27. Bijlsma FJ, Bruggink AH, Hartman M, et al. No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. Tissue Antigens 2001; 57: 151-3.